業績

{ 15件 }

Yamamoto K, Miyoshi H, Cho KY, Nakamura A, Atsumi T. Protective effect of perilipin1 overexpression in macrophages on progression of atherosclerosis.

Atherosclerosis. in press. (PMID 29365559)

  • 2018
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Oita Mayuko, Miyoshi Hideaki, Ohno Kota, Nakamura Akinobu, Cho Kyu Yong, Nomoto Hiroshi, Yamamoto Kohei, Omori Kazuno, Manda Naoki, Kurihara Yoshio, Aoki Shin, Atsumi Tatsuya.  Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes - Randomized controlled study(PMID: 29093280)
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Nomoto H, Miyoshi H.The difference between SGLT2 and DPP-4 inhibitors on glucose fluctuation in patients with type 2 diabetes. British Journal of Research. 2017, 4(3): 21
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/総説
Nomoto H, Oita M.Thyrotoxicosis in Graves’ disease with invasive laryngeal cancer. Internal Medicine.
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告
Nomoto H, Miyoshi H, Nakamura A, Nagai S, Kitao N, Shimizu C, Atsumi T. A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.Medicine (Baltimore). (PMID 28953654)
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告
Kitao N, Miyoshi H, Furumoto T, Ono K, Nomoto H, Miya A, Yamamoto C, Inoue A, Tsuchida K, Manda N, Kurihara Y, Aoki S, Nakamura A, Atsumi T. The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3) Cardiovascular Diabetology in press (PMID:29017497)
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Kameda A, Nakamura A, Kondo Y, Kimura M, Terauchi Y. Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial. Diabetol Int. 2017, in press
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告
Nomoto H, Miyoshi H, Sugawara H, Ono K, Yanagiya S, Oita M, Nakamura A, Atsumi T. A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin. Diabetol Metab Syndr. 2017, in press (PMID:28725273)
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/原著
Hiroshi Nomoto, Hideaki Miyoshi, Akinobu Nakamura, So Nagai, Chikara Shimizu and Tatsuya Atsumi. Potential importance of histopathological analysis in thyroidal diseases with high serum IgG4 levels, Internal Medicine, in press
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/letter
Aki Kondo, Akinobu Nakamura, Jun Takeuchi, Hideaki Miyoshi, Tatsuya Atsumi. Insulin-induced distant-site lipoatrophy.Diabetes Care, in press (PMID:28396362).
  • 2017
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告